E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/19/2009 in the Prospect News Distressed Debt Daily.

Quigley DIP financing extended to March 10

By Caroline Salls

Pittsburgh, Feb. 19 - Quigley Co. Inc.'s debtor-in-possession financing was extended to March 10 under a bridge order filed Thursday with the U.S. Bankruptcy Court for the Southern District of New York.

As previously reported, the company has asked the court to extend the DIP financing to Aug. 18, 2009 and for approval to use up to $45 million of cash collateral.

However, since the facility was scheduled to expire on Feb. 19 and the hearing on the extension will not be held until March 10, the court approved the bridge extension.

Quigley said it is requesting the extension and cash collateral use so it has continued access to financing, if needed, while it works with its official committee of unsecured creditors, parent Pfizer Inc. and its future asbestos claimant representative toward confirmation of a consensual plan of reorganization.

The company said it has never drawn on its DIP facility because it has been funding its operations through the use of cash collateral.

Quigley, a unit of Pfizer Inc., filed for bankruptcy on Sept. 3, 2004. Its Chapter 11 case number is 04-15739.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.